InvestorsHub Logo
Followers 35
Posts 1771
Boards Moderated 0
Alias Born 09/25/2012

Re: None

Friday, 06/14/2019 2:07:24 AM

Friday, June 14, 2019 2:07:24 AM

Post# of 34770
what do you guys make of the pancreatic cancer phase 2 study? I mean it started off with 10 patients and immediately grew with interest in 30 patients. Does that mean there were hints of efficacy with MultiTAA and many people wanted to get in? How do you view this for Marker Therapeutics?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News